lysine acetylsalicylate + clopidogrel

The combination of lysine acetylsalicylate and clopidogrel is a dual antiplatelet therapy used primarily for cardiovascular conditions. Lysine acetylsalicylate (L-ASA) is a soluble form of aspirin that can be administered both orally and intravenously, while clopidogrel is an antiplatelet agent that works through a different mechanism. ## Pharmacology Lysine acetylsalicylate works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), which prevents the production of prostaglandins and thromboxane A2[6]. This inhibition reduces inflammation and prevents platelets from aggregating. The acetyl group of acetylsalicylate binds irreversibly to a serine residue in the COX-1 enzyme, leading to its inhibition for the lifespan of the platelet (7-10 days)[6]. Clopidogrel is a prodrug that requires a two-step activation to form its active thiol-containing metabolite[7]. This active form irreversibly binds to P2Y12 ADP receptors on platelets, preventing ADP binding, activation of the glycoprotein GPIIb/IIIa complex, and subsequent platelet aggregation[7]. When combined, these medications provide complementary antiplatelet effects through different mechanisms, offering enhanced protection against thrombotic events compared to either agent alone[1]. ## Clinical Applications The combination is primarily used in: - Acute coronary syndrome (ACS) - Prevention of myocardial infarction - Prevention of stroke - Management of peripheral arterial disease - During and after coronary stent placement Studies have shown that the administration of lysine acetylsalicylate with clopidogrel is as effective as the combination of regular aspirin with clopidogrel in inhibiting platelet aggregation[1]. The intravenous form of lysine acetylsalicylate may provide faster onset of action compared to oral aspirin, which is particularly beneficial in acute settings like ST-segment elevation myocardial infarction[2]. ## Advantages The lysine acetylsalicylate component offers several advantages over regular aspirin: - Fewer gastrointestinal side effects - Available in both oral and intravenous forms - Faster absorption when administered intravenously - Comparable or potentially superior platelet inhibition ## Side Effects and Precautions As with any antiplatelet therapy, the main concern is increased bleeding risk, which can be severe or life-threatening[10]. Other potential side effects include: - Gastrointestinal issues (though reduced with lysine acetylsalicylate compared to regular aspirin) - Allergic reactions - Bruising and prolonged bleeding time - Potential for drug interactions with other medications The combination should be used with caution in patients with a history of bleeding disorders, recent surgery, or those taking other medications that affect blood clotting.

Other names

L-ASA + clopidogrel